| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/13/2007 | CA2644856A1 Human embryonic stem cell methods and podxl expression |
| 09/13/2007 | CA2644782A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | CA2644774A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | CA2644588A1 Truncated proteins as cancer markers |
| 09/13/2007 | CA2644170A1 Humanized anti-cd20 monoclonal antibody |
| 09/13/2007 | CA2643790A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 09/13/2007 | CA2638833A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 09/12/2007 | EP1832656A1 Method for isolating and using fungal hemolysin |
| 09/12/2007 | EP1832654A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832605A1 Neural cell adhesion molecule (NCAM) binding antibodies |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
| 09/12/2007 | EP1831694A2 Eph receptor tumor biomarkers |
| 09/12/2007 | EP1831693A2 Use of pta peptides for stratification of individuals having cancer |
| 09/12/2007 | EP1831370A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/12/2007 | EP1831368A2 Cancer treatment |
| 09/12/2007 | EP1831258A2 Monoclonal antibodies against nkg2a |
| 09/12/2007 | EP1831257A1 Humanized antibody specific for tumor necrosis factor-alpha |
| 09/12/2007 | EP1831256A1 Immunoglobulins comprising predominantly a galglcnacman5glcnac2 glycoform |
| 09/12/2007 | EP1831255A1 Monoclonal and polyclonal antibodies to equine hemoglobin and apparatus and methods using the antibodies and/or peroxidase reactions in the identification and localization of ulcers in equines |
| 09/12/2007 | EP1831253A1 Combination therapy for b cell disorders |
| 09/12/2007 | EP1830924A1 Prevention of thrombus formation and/or stabilization |
| 09/12/2007 | EP1830881A2 Combining therapies targeting multiple toll-like receptors and use thereof |
| 09/12/2007 | EP1532175A4 Humanized antibody and process for preparing same |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1320542B9 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1257632B1 Simultaneous stimulation and concentration of cells |
| 09/12/2007 | EP1224266B1 Lysosomal targeting pathway enzymes |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP0993613B1 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 09/12/2007 | EP0970127B1 Induction of immunological tolerance to a therapeutic antibody using variants of the said therapeutic antibody |
| 09/12/2007 | EP0964874B1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101035810A Modulators of hepatocyte growth factor activator |
| 09/12/2007 | CN101035809A Humanized anti-tag-72 monoclonal antibodies |
| 09/12/2007 | CN101035808A Humanized anti-CMET antagonists |
| 09/12/2007 | CN101035807A Diagnosis and treatment of SIGLEC-6 associated diseases |
| 09/12/2007 | CN101035804A Modified HIV-1 peptides and use thereof in the detection of anti-HIV antibodies |
| 09/12/2007 | CN101035566A Immunotherapy of autoimmune disorders |
| 09/12/2007 | CN101035564A Humanized anti-5T4 antibodies and anti-5T4 antibody/calicheamicin conjugates |
| 09/12/2007 | CN100336903C Extracting norfibroase from snake venom and preparation process for liquid drugs injection of norfibroase |
| 09/12/2007 | CN100336828C Myopodin antibody preparation method |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268218 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 09/11/2007 | US7268208 Solubility in aqueous solvents; for use in diagnosis, therapy |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268118 Thymosin β4 compositions |
| 09/11/2007 | US7268110 Agents for preventing and treating thrombocytopenia |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267960 Therapy for disease, infections; antiinflammatory agents; modulate cellular adhesion molecules; generation human dendritic cells; anticancer agents; bactericides |
| 09/11/2007 | US7267942 Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 09/11/2007 | US7267824 Veterinary medicine; induce immunology response |
| 09/11/2007 | US7267821 Antitumor agents; leukemia; |
| 09/11/2007 | US7267820 Detecting in body fluid an autoantibody to epitopes of muscle tyrosine kinase |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | CA2172963C Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 09/11/2007 | CA2164498C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 09/07/2007 | WO2007101202A1 Cell-targeted ikb and methods for the use thereof |
| 09/07/2007 | WO2007100643A2 Methods of using antibodies against human il-22 |
| 09/07/2007 | WO2007100248A2 Adir related polymorphisms and applications thereof |
| 09/07/2007 | WO2007100211A1 Sisp-1, a novel p53 target gene and use thereof |
| 09/07/2007 | WO2007100083A1 Modified antibody with enhanced bioactivity |
| 09/07/2007 | WO2007099988A1 α-1,6-FUCOSYLTRANSFERASE MUTANT AND USE THEREOF |
| 09/07/2007 | WO2007099852A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 09/07/2007 | WO2007099346A1 Binding members for ghrelin |
| 09/07/2007 | WO2007098934A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | WO2007098718A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007098548A1 A molecule and chimeric molecules thereof |
| 09/07/2007 | WO2007098547A1 A molecule and chimeric molecules thereof |
| 09/07/2007 | WO2007084001A3 Means and methods for modulating stem cell mobilization |
| 09/07/2007 | WO2007077028A3 Antibodies directed to her-3 and uses thereof |
| 09/07/2007 | WO2007075915A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007075914A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007038392A3 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 09/07/2007 | WO2006093923A8 Treatment of bone disorders |
| 09/07/2007 | WO2006020541A3 Methods for synthesizing polypeptides |
| 09/07/2007 | WO2005094259A8 Leptin binding domain compositions and methods thereto |
| 09/07/2007 | WO2005011605A3 Combination therapies for multiple sclerosis |
| 09/07/2007 | CA2644595A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | CA2644426A1 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2642570A1 Methods of using antibodies against human il-22 |
| 09/07/2007 | CA2638869A1 Humanized anti-ghrelin antibodies |
| 09/07/2007 | CA2638822A1 Adir related polymorphisms and applications thereof |
| 09/07/2007 | CA2638804A1 Modified antibodies with enhanced biological activities |
| 09/06/2007 | US20070209082 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |
| 09/06/2007 | US20070207943 Interleukins-21 and 22 |
| 09/06/2007 | US20070207539 Lymphocytes; immunoglobulins; point mutations |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207521 Novel phospholipases and uses thereof |
| 09/06/2007 | US20070207510 Methods and compounds for lymphoma cell detection and isolation |